Status:
RECRUITING
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
Lead Sponsor:
Guangdong Women and Children Hospital
Conditions:
Neonatal Disease
Eligibility:
All Genders
1-1 years
Brief Summary
1\. Explore 32 weeks of premature infants or maternal pregnancy infection of newborn septic shock maternal influence factors. 2. Through maternal blood samples before delivery and labor cord blood sam...
Detailed Description
The birth cohort was established with 32 weeks of premature infants or maternal infection during pregnancy.Whole proteomic analysis was performed on maternal blood before delivery and umbilical cord b...
Eligibility Criteria
Inclusion
- All ≤32-week premature infants admitted to our NICU; All newborns delivered by the mother infected during pregnancy
Exclusion
- Not delivered in our hospital; congenital cardiovascular development malformation, fetal malformation, genetic metabolic diseases, etc
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT06206590
Start Date
November 1 2023
End Date
December 31 2025
Last Update
January 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Women and Children Hospital
Guangzhou, Guangdong, China, 510000